# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-119251
Filing Date
2024-10-31
Accepted
2024-10-31 08:00:21
Documents
53
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mrus-20240930.htm iXBRL | 10-Q | 2492123
2 | EX-31.1 | mrus-ex31_1.htm | EX-31.1 | 16449
3 | EX-31.2 | mrus-ex31_2.htm | EX-31.2 | 16125
4 | EX-32.1 | mrus-ex32_1.htm | EX-32.1 | 13578
| Complete submission text file | 0000950170-24-119251.txt |  | 8622794

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | mrus-20240930.xsd | EX-101.SCH | 848826
55 | EXTRACTED XBRL INSTANCE DOCUMENT | mrus-20240930_htm.xml | XML | 1750396

Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37773 | Film No.: 241412503
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)